Table of Contents 1 Market Overview 1.1 Monoclonal antibodies (mAbs) Biosimilars Introduction 1.2 Market Analysis by Type 1.2.1 Erythropoietin (EPO) 1.2.2 Human Growth Hormone (HGH) 1.2.3 Granulocyte- Colony Stimulating Factor (G-CSF) 1.2.4 Monoclonal Antibody (mAb) 1.2.5 Insulin 1.2.6 Interferon (IFN) 1.2.7 Others 1.3 Market Analysis by Applications 1.3.1 Anti-Cancer 1.3.2 Anti-Inflammatory/Autoimmune 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Biocon 2.1.1 Business Overview 2.1.2 Monoclonal antibodies (mAbs) Biosimilars Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Biocon Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Celltrion 2.2.1 Business Overview 2.2.2 Monoclonal antibodies (mAbs) Biosimilars Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Celltrion Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Dr. Reddy's Laboratories 2.3.1 Business Overview 2.3.2 Monoclonal antibodies (mAbs) Biosimilars Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Hospira 2.4.1 Business Overview 2.4.2 Monoclonal antibodies (mAbs) Biosimilars Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Hospira Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 3SBio 2.5.1 Business Overview 2.5.2 Monoclonal antibodies (mAbs) Biosimilars Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 3SBio Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Accord Healthcare 2.6.1 Business Overview 2.6.2 Monoclonal antibodies (mAbs) Biosimilars Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 AET Biotech 2.7.1 Business Overview 2.7.2 Monoclonal antibodies (mAbs) Biosimilars Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Allergan 2.8.1 Business Overview 2.8.2 Monoclonal antibodies (mAbs) Biosimilars Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Allergan Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Amega Biotech 2.9.1 Business Overview 2.9.2 Monoclonal antibodies (mAbs) Biosimilars Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Others 2.10.1 Business Overview 2.10.2 Monoclonal antibodies (mAbs) Biosimilars Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Others Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Monoclonal antibodies (mAbs) Biosimilars Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 Monoclonal antibodies (mAbs) Biosimilars Manufacturer Market Share in 2017 3.3.2 Top 6 Monoclonal antibodies (mAbs) Biosimilars Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global Monoclonal antibodies (mAbs) Biosimilars Market Analysis by Regions 4.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales, Revenue and Market Share by Regions 4.1.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales and Market Share by Regions (2013-2018) 4.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Market Share by Regions (2013-2018) 4.2 North America Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 4.3 Europe Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 4.5 South America Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 5 North America Monoclonal antibodies (mAbs) Biosimilars by Countries 5.1 North America Monoclonal antibodies (mAbs) Biosimilars Sales, Revenue and Market Share by Countries 5.1.1 North America Monoclonal antibodies (mAbs) Biosimilars Sales and Market Share by Countries (2013-2018) 5.1.2 North America Monoclonal antibodies (mAbs) Biosimilars Revenue and Market Share by Countries (2013-2018) 5.2 United States Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 5.3 Canada Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 5.4 Mexico Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 6 Europe Monoclonal antibodies (mAbs) Biosimilars by Countries 6.1 Europe Monoclonal antibodies (mAbs) Biosimilars Sales, Revenue and Market Share by Countries 6.1.1 Europe Monoclonal antibodies (mAbs) Biosimilars Sales and Market Share by Countries (2013-2018) 6.1.2 Europe Monoclonal antibodies (mAbs) Biosimilars Revenue and Market Share by Countries (2013-2018) 6.2 Germany Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 6.3 UK Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 6.4 France Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 6.5 Russia Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 6.6 Italy Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 7 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars by Countries 7.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue and Market Share by Countries (2013-2018) 7.2 China Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 7.3 Japan Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 7.4 Korea Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 7.5 India Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 7.6 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 8 South America Monoclonal antibodies (mAbs) Biosimilars by Countries 8.1 South America Monoclonal antibodies (mAbs) Biosimilars Sales, Revenue and Market Share by Countries 8.1.1 South America Monoclonal antibodies (mAbs) Biosimilars Sales and Market Share by Countries (2013-2018) 8.1.2 South America Monoclonal antibodies (mAbs) Biosimilars Revenue and Market Share by Countries (2013-2018) 8.2 Brazil Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 8.3 Argentina Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 8.4 Colombia Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 9 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars by Countries 9.1 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 9.3 UAE Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 9.4 Egypt Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 9.5 Nigeria Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 9.6 South Africa Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) 10 Global Monoclonal antibodies (mAbs) Biosimilars Market Segment by Type 10.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales and Market Share by Type (2013-2018) 10.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Market Share by Type (2013-2018) 10.2 Erythropoietin (EPO) Sales Growth and Price 10.2.1 Global Erythropoietin (EPO) Sales Growth (2013-2018) 10.2.2 Global Erythropoietin (EPO) Price (2013-2018) 10.3 Human Growth Hormone (HGH) Sales Growth and Price 10.3.1 Global Human Growth Hormone (HGH) Sales Growth (2013-2018) 10.3.2 Global Human Growth Hormone (HGH) Price (2013-2018) 10.4 Granulocyte- Colony Stimulating Factor (G-CSF) Sales Growth and Price 10.4.1 Global Granulocyte- Colony Stimulating Factor (G-CSF) Sales Growth (2013-2018) 10.4.2 Global Granulocyte- Colony Stimulating Factor (G-CSF) Price (2013-2018) 10.5 Monoclonal Antibody (mAb) Sales Growth and Price 10.5.1 Global Monoclonal Antibody (mAb) Sales Growth (2013-2018) 10.5.2 Global Monoclonal Antibody (mAb) Price (2013-2018) 10.6 Insulin Sales Growth and Price 10.6.1 Global Insulin Sales Growth (2013-2018) 10.6.2 Global Insulin Price (2013-2018) 10.7 Interferon (IFN) Sales Growth and Price 10.7.1 Global Interferon (IFN) Sales Growth (2013-2018) 10.7.2 Global Interferon (IFN) Price (2013-2018) 10.8 Others Sales Growth and Price 10.8.1 Global Others Sales Growth (2013-2018) 10.8.2 Global Others Price (2013-2018) 11 Global Monoclonal antibodies (mAbs) Biosimilars Market Segment by Application 11.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Application (2013-2018) 11.2 Anti-Cancer Sales Growth (2013-2018) 11.3 Anti-Inflammatory/Autoimmune Sales Growth (2013-2018) 12 Monoclonal antibodies (mAbs) Biosimilars Market Forecast (2018-2023) 12.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales, Revenue and Growth Rate (2018-2023) 12.2 Monoclonal antibodies (mAbs) Biosimilars Market Forecast by Regions (2018-2023) 12.2.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Forecast (2018-2023) 12.2.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Forecast (2018-2023) 12.2.3 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Forecast (2018-2023) 12.2.4 South America Monoclonal antibodies (mAbs) Biosimilars Market Forecast (2018-2023) 12.2.5 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Forecast (2018-2023) 12.3 Monoclonal antibodies (mAbs) Biosimilars Market Forecast by Type (2018-2023) 12.3.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales Forecast by Type (2018-2023) 12.3.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Share Forecast by Type (2018-2023) 12.4 Monoclonal antibodies (mAbs) Biosimilars Market Forecast by Application (2018-2023) 12.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales Forecast by Application (2018-2023) 12.4.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Monoclonal antibodies (mAbs) Biosimilars Picture Table Product Specifications of Monoclonal antibodies (mAbs) Biosimilars Figure Global Sales Market Share of Monoclonal antibodies (mAbs) Biosimilars by Types in 2017 Table Monoclonal antibodies (mAbs) Biosimilars Types for Major Manufacturers Figure Erythropoietin (EPO) Picture Figure Human Growth Hormone (HGH) Picture Figure Granulocyte- Colony Stimulating Factor (G-CSF) Picture Figure Monoclonal Antibody (mAb) Picture Figure Insulin Picture Figure Interferon (IFN) Picture Figure Others Picture Figure Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Applications in 2017 Figure Anti-Cancer Picture Figure Anti-Inflammatory/Autoimmune Picture Figure United States Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Canada Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Germany Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure France Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure UK Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Russia Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Italy Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure China Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Japan Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Korea Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure India Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Monoclonal antibodies (mAbs) Biosimilars Revenue (Value) and Growth Rate (2013-2023) Table Biocon Basic Information, Manufacturing Base and Competitors Table Biocon Monoclonal antibodies (mAbs) Biosimilars Type and Applications Table Biocon Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Celltrion Basic Information, Manufacturing Base and Competitors Table Celltrion Monoclonal antibodies (mAbs) Biosimilars Type and Applications Table Celltrion Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors Table Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Type and Applications Table Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Hospira Basic Information, Manufacturing Base and Competitors Table Hospira Monoclonal antibodies (mAbs) Biosimilars Type and Applications Table Hospira Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table 3SBio Basic Information, Manufacturing Base and Competitors Table 3SBio Monoclonal antibodies (mAbs) Biosimilars Type and Applications Table 3SBio Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Accord Healthcare Basic Information, Manufacturing Base and Competitors Table Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Type and Applications Table Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AET Biotech Basic Information, Manufacturing Base and Competitors Table AET Biotech Monoclonal antibodies (mAbs) Biosimilars Type and Applications Table AET Biotech Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Allergan Basic Information, Manufacturing Base and Competitors Table Allergan Monoclonal antibodies (mAbs) Biosimilars Type and Applications Table Allergan Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Amega Biotech Basic Information, Manufacturing Base and Competitors Table Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Type and Applications Table Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Others Basic Information, Manufacturing Base and Competitors Table Others Monoclonal antibodies (mAbs) Biosimilars Type and Applications Table Others Monoclonal antibodies (mAbs) Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Monoclonal antibodies (mAbs) Biosimilars Sales by Manufacturer (2016-2017) Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Manufacturer in 2016 Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Manufacturer in 2017 Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Manufacturer (2016-2017) Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Manufacturer in 2016 Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Manufacturer in 2017 Figure Top 3 Monoclonal antibodies (mAbs) Biosimilars Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Monoclonal antibodies (mAbs) Biosimilars Manufacturer (Revenue) Market Share in 2017 Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate (2013-2018) Table Global Monoclonal antibodies (mAbs) Biosimilars Sales by Regions (2013-2018) Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Regions (2013-2018) Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Regions (2013-2018) Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Regions in 2013 Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Regions in 2017 Figure North America Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Europe Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure South America Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure North America Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate (2013-2018) Table North America Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2013-2018) Table North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2013-2018) Figure North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries in 2013 Figure North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries in 2017 Table North America Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2013-2018) Table North America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2013-2018) Figure North America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries in 2013 Figure North America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries in 2017 Figure United States Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Canada Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Mexico Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Europe Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate (2013-2018) Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2013-2018) Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2013-2018) Table Europe Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2013-2018) Figure Europe Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries in 2016 Figure Europe Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries in 2017 Figure Germany Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure UK Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure France Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Russia Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Italy Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate (2013-2018) Table Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2013-2018) Table Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries 2017 Table Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2013-2018) Figure Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries 2017 Figure China Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Japan Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Korea Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure India Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure South America Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate (2013-2018) Table South America Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2013-2018) Table South America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2013-2018) Figure South America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries in 2017 Table South America Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2013-2018) Table South America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2013-2018) Figure South America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries in 2017 Figure Brazil Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Argentina Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Colombia Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate (2013-2018) Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2013-2018) Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries in 2017 Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2013-2018) Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries in 2013 Figure Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries in 2017 Figure Saudi Arabia Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure UAE Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Egypt Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure Nigeria Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Figure South Africa Monoclonal antibodies (mAbs) Biosimilars Sales and Growth Rate (2013-2018) Table Global Monoclonal antibodies (mAbs) Biosimilars Sales by Type (2013-2018) Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Share by Type (2013-2018) Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Type (2013-2018) Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Type (2013-2018) Figure Global Erythropoietin (EPO) Sales Growth (2013-2018) Figure Global Erythropoietin (EPO) Price (2013-2018) Figure Global Human Growth Hormone (HGH) Sales Growth (2013-2018) Figure Global Human Growth Hormone (HGH) Price (2013-2018) Figure Global Granulocyte- Colony Stimulating Factor (G-CSF) Sales Growth (2013-2018) Figure Global Granulocyte- Colony Stimulating Factor (G-CSF) Price (2013-2018) Figure Global Monoclonal Antibody (mAb) Sales Growth (2013-2018) Figure Global Monoclonal Antibody (mAb) Price (2013-2018) Figure Global Insulin Sales Growth (2013-2018) Figure Global Insulin Price (2013-2018) Figure Global Interferon (IFN) Sales Growth (2013-2018) Figure Global Interferon (IFN) Price (2013-2018) Figure Global Others Sales Growth (2013-2018) Figure Global Others Price (2013-2018) Table Global Monoclonal antibodies (mAbs) Biosimilars Sales by Application (2013-2018) Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Share by Application (2013-2018) Figure Global Anti-Inflammatory/Autoimmune Sales Growth (2013-2018) Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales, Revenue and Growth Rate (2018-2023) Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Forecast by Regions (2018-2023) Table Global Monoclonal antibodies (mAbs) Biosimilars Market Share Forecast by Regions (2018-2023) Figure North America Sales Monoclonal antibodies (mAbs) Biosimilars Market Forecast (2018-2023) Figure Europe Sales Monoclonal antibodies (mAbs) Biosimilars Market Forecast (2018-2023) Figure Asia-Pacific Sales Monoclonal antibodies (mAbs) Biosimilars Market Forecast (2018-2023) Figure South America Sales Monoclonal antibodies (mAbs) Biosimilars Market Forecast (2018-2023) Figure Middle East and Africa Sales Monoclonal antibodies (mAbs) Biosimilars Market Forecast (2018-2023) Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Forecast by Type (2018-2023) Table Global Monoclonal antibodies (mAbs) Biosimilars Market Share Forecast by Type (2018-2023) Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Forecast by Application (2018-2023) Table Global Monoclonal antibodies (mAbs) Biosimilars Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Biocon Celltrion Dr. Reddy's Laboratories Hospira 3SBio Accord Healthcare AET Biotech Allergan Amega Biotech Others